Timothy Langer
Directeur Financier/CFO chez Myst Therapeutics LLC
Fortune : 2 M $ au 31/05/2024
Profil
Timothy J.
Langer is associated with Myst Therapeutics LLC as the Chief Financial Officer.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/05/2024 | 777 657 ( 3,36% ) | 2 M $ | 31/05/2024 |
Postes actifs de Timothy Langer
| Sociétés | Poste | Début |
|---|---|---|
Myst Therapeutics LLC
 Myst Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Myst Therapeutics LLC develops novel T-cell therapies for solid tumors. The company is based in Glendale, CA. The CEO of the company is Sammy J. Farah. Myst Therapeutics was acquired by Turnstone Biologics, Inc. on January 20, 2021. | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Myst Therapeutics LLC
Myst Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Myst Therapeutics LLC develops novel T-cell therapies for solid tumors. The company is based in Glendale, CA. The CEO of the company is Sammy J. Farah. Myst Therapeutics was acquired by Turnstone Biologics, Inc. on January 20, 2021. | Commercial Services |
